Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2009-05-04
2011-12-06
Gamett, Daniel C (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S007500, C514S008300, C514S009100, C514S013300, C530S300000, C530S327000
Reexamination Certificate
active
08071549
ABSTRACT:
The present invention relates to a compound comprising the third Immunoglobulin (Ig3) module, and/or the fourth Immunoglobulin (Ig4) module, and/or the fifth immunoglobulin (Ig5) module, and/or the first Fibronectin III (Fn3,1) module, and/or the second Fibronectin III (Fn3,2) module of neural cell adhesion molecule (NCAM), or a fragment, or a variant thereof, capable of interacting with an Fibroblast Growth Factor (FGF) receptor and/or Adenosine-Tri-Phosphate (ATP) and/or L1, and thereby the compounds are capable of inducing differentiation, modulating proliferation, stimulate regeneration, neuronal plasticity and/or survival of cells. Further, the present invention relates to a pharmaceutical composition comprising said compound, a process of producing a pharmaceutical composition and the use of said compound.
REFERENCES:
patent: 4599311 (1986-07-01), Kawasaki
patent: 4683202 (1987-07-01), Mullis
patent: 5010175 (1991-04-01), Rutter et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5693488 (1997-12-01), Fang et al.
patent: 5837813 (1998-11-01), Ruoslahti et al.
patent: 5840689 (1998-11-01), Daniloff
patent: 6313265 (2001-11-01), Phillips et al.
patent: 6576607 (2003-06-01), Schachner
patent: 6749850 (2004-06-01), Finkelstein et al.
patent: 7167819 (2007-01-01), Gibson et al.
patent: 7504490 (2009-03-01), Weinstock et al.
patent: 2009/0105149 (2009-04-01), Albrechtsen et al.
patent: WO 00/18791 (2000-04-01), None
patent: WO 00/24770 (2000-05-01), None
patent: WO 01/16166 (2001-03-01), None
patent: WO 01/96364 (2001-12-01), None
patent: WO 03/016351 (2003-02-01), None
patent: WO 2004/056865 (2004-07-01), None
Kolkova et al., Journal of Neuroscience, Mar. 15, 2000, 20(6):2238-2246.
Dickson, et al., “Human Muscle Neural Cell Adhesion Molecule (N-CAM): Identification of a Muscle-Specific Sequence in the Extracellular Domain”,Cell, vol. 50, pp. 1119-1130, Sep. 25, 1987.
Rønn, et al., “Neurite Outgrowth Induced by a Synthetic Peptide Ligand of Neural Cell Adhesion Molecule Requires Fibroblast Growth Factor Receptor Activation”,Journal of Neurochemistry, vol. 75, pp. 665-671, 2000.
Stahlhut, et al., “NCAM-Fibronectin-Type-III-Domain Substrata With and Without a Six-Amino-Acid-Long Proline-Rich Insert Increase the Dendritic and Axonal Arborization of Spinal Motoneurons”,Journal of Neuroscience Research, vol. 48, pp. 112-121, 1997.
USPTO, Final Rejection, mailed Jan. 18, 2011 on Application of Albrechtsen, U.S. Appl. No. 10/567,365.
U.S. Appl. No. 12/745,129, filed May 27, 2001, Berezin, et al.
Alber et al., “Nucleotide Sequence of the Triose Phosphate Isomerase Gene ofSaccharomyces cerevisiae”, J. of Molecular and Applied Genetics, vol. 1, No. 5, pp. 419-434, 1982.
Altman et al., “Postnatal Development of Locomotion in the Laboratory Rat”,Anim. Behav., vol. 23, pp. 896-920, 1975.
Beaucage et al., “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates forDeoxypolynucleotide Synthesis”,Tetrahedron Letters, vol. 22, No. 20, pp. 1859-1862, 1981.
Bruses, et al., “Roles, regulation, and mechanism of polysialic acid function during neural development”,Biochemie, vol. 83, pp. 635-643, 2001.
Cambon et al., “A Synthetic Neural Cell Adhesion Molecule Mimetic Peptide Promotes Synaptogenesis. Enhances Presynaptic Function, and Facilitates Memory Consolidation”,J. of Neuroscience, vol. 24, No. 17, pp. 4197-4204, Apr. 28, 2004.
Cancilla et al., “Fibroblast growth factor receptors and their ligands in the adult rat kidney”,Kidney International, vol. 60, pp. 147-155, 2001.
Castelnau et al., “Prion Protein Gene Expression in Cultured Astrocytes Treated by Recombinant Growth Hormone and Insulin-like Growth Factor”,Experimental Neurology, vol. 130, pp. 407-410, 1994.
Cerbone et al., “Behavioral Habituation to Spatial Novelty: Interference and Noninterference Studies”,Neuroscience and Behavioral Reviews, vol. 18, No. 4, pp. 497-518, 1994.
Cheng et al., “NGF and bFGF Protect Rat Hippocampal and Human Cortical Neurons against Hypoglycemic Damage by Stabilizing Calcium Homeostasis”,Neuron, vol. 7, pp. 1031-1041, Dec. 1991.
Clayton et al., “Noradrenergic Receptor Blockade of the NTS Attenuates the Mnemonic Effects of Epinephrine in an Appetitive Light-Dark Discrimination Learning Task”,Neurobiology of Learning and Memory, vol. 74, pp. 135-145, 2000.
Cordero et al., “Prior exposure to a single stress session facilitates subsequent contextual fear conditioning in rats—Evidence for a role of Corticosterone”,Hormones and Behavior, vol. 44, pp. 338-345, 2003.
Corsaro et al., “Enhancing the Efficiency of DNA-Mediated Gene Transfer in Mammalian Cells”,Somatic Cell Genetics, vol. 7, No. 5, pp. 603-616, 1981.
Cotman et al., “Cell Adhesion Molecules in Neural Plasticity and Pathology: Similar Mechanisms, Distinct Organizations”,Progress in Neurobiology, vol. 55, pp. 659-669, 1998.
Cremer, et al., “NCAM is essential for axonal growth and fasciculation in the hippocampus”,Mol. Cell Neurosci., vol. 8, pp. 323-335, 1997.
D'Mello et al., “Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP”,Proc. Natl. Acad. Sci. USA, vol. 90, pp. 10989-10993, Dec. 1993.
Dantzer, et al., “Modulation of social memory in male rats by neurohypophyseal peptides”,Psychopharmacology, vol. 91, pp. 363-368, 1987.
Defoort et al., “A rational design of synthetic peptide vaccine with a built-in adjuvant”,Int. J. Peptide Protein Res., vol. 40, pp. 214-221, 1992.
Delobette et al., “In vitro aggregation facilitates β-amyloid peptide-(25-35)-induced amnesia in the rat”,European J. of Pharmacology, vol. 319, pp. 1-4, 1997.
Devlin, et al., “Random Peptide Libraries: A Source of Specific Protein Binding Molecules”,Science, vol. 249, pp. 404-406, Jul. 27, 1990.
Dickson, et al., “Human Muscle Neural Cell Adhesion Molecule (N-CAM): Identification of a Muscle-Specific Sequence in the Extracellular Domain”,Cell, vol. 50, pp. 1119-1130, Sep. 25, 1987.
Drejer et al., “Selection of a Pure Cerebellar Granule Cell Culture by Kainate Treatment”,Neurochemical Research, vol. 14, No. 8, pp. 751-754, 1989.
Drijfhout et al., “A new synthetic functionalized antigen carrier”,Int. J. Peptide Protein Res., vol. 37, No. 27-32, 1991.
Dryland et al., “Peptide Synthesis. Part 8. A System for Solid-phase Synthesis Under Low Pressure Continuous Flow Conditions”,J. Chem. Soc Perkin Trans. I, pp. 125-137, 1986.
Eldadah et al., “Ribozyme-Mediated Inhibition of Caspase-3 Protects Cerebellar Granule Cells from Apoptosis Induced by Serum-Potassium Deprivation”,J. Neuroscience, vol. 20, No. 1, pp. 179-186, Jan. 1, 2000.
Fodor, et al., “Light-Directed, Spatially Addresable Parallel Chemical Synthesis”,Science, vol. 251, pp. 767-773, Feb. 15, 1991.
Goodwin et al., “A simple procedure for solid-phase synthesis of peptide nucleic acids with N-terminal cysteine”,Bioorganic&Medicinal Chemistry Letters, vol. 8, pp. 2231-2234, 1998.
Geysen, et al., “Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid”,Proc. Natl. Acad. Sci. USA, vol. 81, pp. 3998-4002, Jul. 1984.
Geysen, et al., “Chemistry of Antibody Binding to a Protein”,Science, vol. 235, pp. 1184-1190, Mar. 6, 1987.
Geysen, et al., “Strategies for epitope analysis using peptide synthesis”,Journal of Immunological Methods, vol. 102, pp. 259-274, 1987.
Graham et al., “A New Technique for the Assay of Infectivity of Human Adenovirus 5 DNA”,Virology, vol. 52, pp. 456-467, 1973.
Hart et al., “Attenuation of FGF signaling in mouse β-cells leads to diabetes”,Nature, vol. 408, pp. 864-868, Dec. 14, 20
Berezin Vladimir
Bock Elisabeth
Kiselyov Vladislav V
Skladchikova Galina
Cooper Iver P.
Gamett Daniel C
LandOfFree
Compounds capable of affecting differentiation,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds capable of affecting differentiation,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds capable of affecting differentiation,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4299590